Magnetar Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.02M Buy
+5,196
New +$2.07M 0.02% 335
2026
Q2
– Sell
-799
Closed -$228K – 1250
2026
Q1
$228K Buy
+799
New +$263K ﹤0.01% 854
2025
Q2
– Sell
-4,432
Closed -$1.93M – 962
2025
Q1
$1.93M Buy
4,432
+2,471
+126% +$992K 0.03% 279
2024
Q4
$723K Sell
1,961
-7,485
-79% -$3.13M 0.02% 313
2024
Q3
$4.91M Buy
9,446
+1,638
+21% +$875K 0.11% 153
2024
Q2
$4.23M Buy
7,808
+6,558
+525% +$3.47M 0.09% 136
2024
Q1
$648K Buy
+1,250
New +$622K 0.01% 284
2023
Q4
– Sell
-5,891
Closed -$2.57M – 422
2023
Q3
$2.57M Buy
5,891
+1,851
+46% +$840K 0.07% 164
2023
Q2
$1.79M Sell
4,040
-3,126
-44% -$1.44M 0.04% 226
2023
Q1
$3.29M Sell
7,166
-60,382
-89% -$28.7M 0.06% 215
2022
Q4
$34.6M Buy
+67,548
New +$34.3M 0.59% 42
2020
Q3
– Sell
-2,656
Closed -$698K – 670
2020
Q2
$698K Buy
+2,656
New +$709K 0.02% 233
2020
Q1
– Sell
-17,710
Closed -$5.35M – 521
2019
Q4
$5.35M Buy
+17,710
New +$4.87M 0.11% 115
2019
Q2
– Sell
-1,195
Closed -$343K – 482
2019
Q1
$343K Buy
+1,195
New +$346K 0.01% 305
2018
Q4
– Sell
-2,041
Closed -$559K – 354
2018
Q3
$559K Buy
+2,041
New +$530K 0.01% 178
2018
Q2
– Sell
-3,276
Closed -$720K – 554
2018
Q1
$720K Buy
+3,276
New +$770K 0.01% 272
2017
Q4
– Sell
-1,854
Closed -$352K – 753
2017
Q3
$352K Sell
1,854
-14,376
-89% -$2.74M 0.01% 499
2017
Q2
$3.05M Buy
+16,230
New +$2.92M 0.05% 174
2016
Q4
– Sell
-9,573
Closed -$1.2M – 134
2016
Q3
$1.2M Buy
9,573
+4,185
+78% +$540K 0.02% 241
2016
Q2
$708K Buy
+5,388
New +$737K 0.01% 189
2016
Q1
– Sell
-3,201
Closed -$446K – 399
2015
Q4
$446K Buy
+3,201
New +$441K 0.01% 160
2015
Q3
– Sell
-5,294
Closed -$869K – 438
2015
Q2
$869K Sell
5,294
-9,503
-64% -$1.52M 0.01% 187
2015
Q1
$2.28M Buy
+14,797
New +$2.11M 0.04% 144
2014
Q4
– Sell
-12,048
Closed -$1.44M – 195
2014
Q3
$1.44M Buy
+12,048
New +$1.38M 0.02% 147

Other funds holding ELV

Magnetar Financial's ELV Position: Q3 2026 in Review

Magnetar Financial opened a new position in Elevance Health (ELV) in Q3 2026: 5,196 shares worth $2.02M. The stake represents 0.02% of the portfolio and ranks #335 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in ELV as recently as Q1 2026.

Magnetar Financial first reported a position in ELV in Q3 2014 and has held it in 24 quarters since. The position peaked at $34.6M in Q4 2022. 1,604 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Magnetar Financial held 5,196 shares of Elevance Health worth $2.02M as of Q3 2026.
  • Elevance Health was a new Magnetar Financial position in Q3 2026.
  • Elevance Health made up 0.02% of Magnetar Financial's portfolio in Q3 2026, its #335 holding.
  • Magnetar Financial first reported a position in Elevance Health in Q3 2014 and has held it in 24 quarters since.
  • Magnetar Financial's Elevance Health position peaked at $34.6M in Q4 2022.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.